Head-to-head comparison of Rezum vs Urolift for patient with benign prostatic hyperplasia: A systematic review

Usman, Muhammad Alvin Ramadhan and Hasbullah, Asyam Syafiq and Kafalah, Ulinnuha Khirza and Hermarwan, Raih Viguruh (2025) Head-to-head comparison of Rezum vs Urolift for patient with benign prostatic hyperplasia: A systematic review. World Journal of Advanced Research and Reviews, 25 (1). pp. 1391-1398. ISSN 25819615

[thumbnail of WJARR-2025-0166.pdf] Text
WJARR-2025-0166.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike.

Download (568kB)

Abstract

Introduction: Minimally invasive surgical therapies (MISTs) have been developed to treat Benign Prostatic hyperplasia (BPH) while minimizing adverse surgical effect. Most recent developed MIST, Rezum and Urolift, showed effective efficacy in improving, but head-to-head comparison still lacking. This study aims to compare the efficacy and safety of Urolift and Rezum in managing BPH-related LUTS. Methods:A systematic search was conducted in Cochrane, PubMed, EMBASE, SCOPUS and EBSCOhost, identifying observational studies comparing rezum and urolift in BPH patient. Data extraction included demographics, intervention protocols, follow-up duration, and outcomes International Prostate Symptom Score (IPSS) score, IPSS-QoL, sexual function, and reintervention rate. The quality of studies was assessed using the Newcastle-Ottawa Scale. Results:Two cohort with a total of 101 patients with BPH were included. At 12 months, Rezum tends to be superior in improving symptoms severity, while at 2 months of follow-up, Urolift outperformed Rezum. Both intervention preserved patient’s sexual function and does not differ significantly. Reintervention rate significantly higher in Urolift compared to Rezum group. Conclusion: Rezum offers a more effective alternative to Urolift for managing BPH in long term setting, with lower reintervention rate and preserved sexual function. In early setting, Urolift showed higher efficacy and rapid improvement compared to Rezum.

Item Type: Article
Uncontrolled Keywords: Rezum; Urolift; Benign Prostatic Hyperplasia; Minimally invasive surgical therapies
Subjects: Q Science > Q Science (General)
R Medicine > RD Surgery
Depositing User: Editor WJARR
Date Deposited: 10 Jul 2025 15:40
Last Modified: 10 Jul 2025 15:40
URI: https://eprint.scholarsrepository.com/id/eprint/268

Actions (login required)

View Item
View Item